Project Type(s):
Clinical Research
TNS uses a device to send currents into the brain and stimulate the trigeminal nerve. This method has proven effective to treat depression and other psychiatric disorders. The research team is working to understand if this approach could help improve executive function and reduce symptoms of ADHD.
Previous studies have shown that this is effective for about half of people with ADHD. Our research team is working to better understand for whom this therapy might be most effective and if this could be a viable new treatment for ADHD.
Please contact us at tnsstudy@seattlechildrens.org.
Project Period:
September 1, 2022 — January 31, 2026
Funding Type(s):
Federal
NIMH
Geographic Area(s):
California, Washington
Patient Population(s):
Children
Targeted Condition(s):
Attention-Deficit/Hyperactivity Disorder (ADHD)
